Different Lipid Soluble Opioids for Gynecologic Laparoscopic Surgery Postoperative Patient-controlled Analgesia
1 other identifier
interventional
180
0 countries
N/A
Brief Summary
The investigators noticed that Body Fat Ratio might have great influence on the efficacy of different lipid soluble anesthetics. The objective of this clinical trial was to compare the effect of that Body Fat Ratio on the efficacy of different lipid soluble anesthetics.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2012
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2013
CompletedFirst Submitted
Initial submission to the registry
June 14, 2013
CompletedFirst Posted
Study publicly available on registry
August 6, 2013
CompletedAugust 6, 2013
August 1, 2013
1.2 years
June 14, 2013
August 3, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
visual analogue pain scores
we evaluate visual analogue pain scores at different time points within 24 hours after surgery
24hour
Secondary Outcomes (1)
nausea & vomiting
24hour
Study Arms (2)
low body fat percentage
EXPERIMENTALbody fat percentage less than 30%
heigh body fat percentage
EXPERIMENTALbody fat percentage more than 30%
Interventions
sufentanil 1ug/ml
sufentanil 0.5ug/ml+morphine 0.25mg/ml
Eligibility Criteria
You may qualify if:
- American Society of Anesthesiologists grade I-II
- adults aged over 20 and below 50 years old,
- non-smoker,
- with normal hepatic and renal function.
You may not qualify if:
- smoker ,
- any kind of mental disorder or
- history use of analgesics for more than 10 consecutive days,
- asthma; and
- those with digestion tract disorder who would get nausea or vomiting much more easily than normal people.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
zhou yan, MD
PKU 1st hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D
Study Record Dates
First Submitted
June 14, 2013
First Posted
August 6, 2013
Study Start
January 1, 2012
Primary Completion
March 1, 2013
Study Completion
March 1, 2013
Last Updated
August 6, 2013
Record last verified: 2013-08